跳至主要内容
临床试验/CTRI/2024/10/074653
CTRI/2024/10/074653尚未招募不适用

Effectiveness of add-on Yoga therapy compared to standard care on Severity of disease and Quality of Life in individuals with Atopic Dermatitis at tertiary care hospital in Rishikesh, Uttarakhand: A Pilot study

CCRYN1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年10月14日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
CCRYN
入组人数
100
试验地点
1
主要终点
EASI scores

研究概览

简要总结

N/A

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Newly Diagnosed cases of Atopic dermatitis Age: ≥18-60 years Residence: Uttarakhand Individuals who are willing to provide informed consent.
  • Individuals with access to smartphones with internet connection.

排除标准

  • Individuals with other skin conditions that could confound the assessment of eczema, such as psoriasis or infections Individuals with co-morbidities e.g. diabetes, autoimmune diseases, cardiovascular disorders, joint disorders, deformities, hypertension, hernia, peptic ulcers, coronary artery disease, chronic renal failure, Anal fissures Pregnant women Females during menstruation as it is contraindicated during yoga intervention.
  • Weak and debilitated patients Individuals with significant cognitive impairments that may hinder their ability to follow instructions during yoga sessions.

结局指标

主要结局

EASI scores

时间窗: Day 0, Day 30/Termination of trial

次要结局

  • DLQI scores
  • Serum cytokines - CCL17/TARC, IL31
  • Serum IgE(Day 0, day 30/Termination of trial)
  • C-reactive protein(Day 0, Day 30/Termination of trial)
  • Neutrophil Lymphocyte ratio(Day 0, Day 30/Termination of trial)
  • Blood eosinophils(Day 0, Day 30/Termination of trial)
  • NFĸB(Day 0, Day 30/Termination of trial)

研究者

发起方
CCRYN
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Vartika Saxena

AIIMS, Rishikesh

研究点 (1)

Loading locations...

相似试验